Breast Cancer Diagnostics Market Research Report with Key Players Analysis, Trends and Growth Forecast till 2022

The global market discussion on breast cancer diagnostics industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on breast cancer diagnostics market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=55

According to a recent study by Fact.MR, the global breast cancer diagnostics market is projected to register a moderate CAGR of 4.7% during the forecast period 2017 to 2022. The report estimates the market to surpass US$ 2,000 Mn in revenues by 2022-end.

In diagnostic platforms of breast cancer, a number of technological advancements have led towards a robust transformation of the global market for breast cancer diagnostics. The emergence of hybrid diagnostics instruments with the provision of an enhanced accuracy have been witnessed in the market. Advancements such as these have been fuelling growth of the global market for breast cancer diagnostics. Surging cases of breast cancer, coupled with growing older women population are anticipated to create potential growth opportunities for breast cancer diagnostics market across the globe. However, lack of skilled as well as trained personnel is expected to inhibit the demand for breast cancer diagnostics during the forecast period.

The most common type of cancer for women across the globe currently is breast cancer. The number of breast cancer cases is expected to witness a rise, leading towards the requirement for efficient and early breast cancer detection. An established method, mammography, adopted in many countries, has recently been observed to provide inconclusive test results. Personalized and risk-adapted therapy are expected to resolve these difficulties. Tomosythesis, which has emerged as a new imaging technology, promises to overcome the challenges incurred in mammography.

Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

Browse Full Report with TOC- https://www.factmr.com/report/55/breast-cancer-diagnostics-market

Table of Content:

Chapter 1 Global Breast Cancer Diagnostics Market – Executive Summary 19

Chapter 2 Global Breast Cancer Diagnostics Market Overview 21
2.1 Introduction 21
2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 21
2.1.2 Global Breast Cancer Diagnostics Market Definition 21
2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 22
2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 22
2.3 Global Breast Cancer Diagnostics Market Dynamics 22
2.3.1 Drivers 22
2.3.2 Restraints 22
2.3.3 Trends 23
2.4 Supply Chain 23
2.5 Epidemiology 23
2.6 List of Distributors 23
2.7 Average Pricing Analysis 23
2.8 Regulations 24
2.9 Key Participants Market Presence (Intensity Map) By Region 24

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 25
3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 25
3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 25
3.1.1.1 Revenue (US$ Mn) Comparison, By Region 25
3.1.1.2 Market Share Comparison, By Region 26
3.1.1.3 Y-o-Y growth Comparison, By Region 27
3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 28
3.1.2.1 Revenue (US$ Mn) Comparison, By Region 28
3.1.2.2 Market Share Comparison, By Region 29
3.1.2.3 Y-o-Y growth Comparison, By Region 30

Continued….

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=55

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.